Inside the Simulation and White Paper Package: Turning WoundScribe Cases into an Approved…
product
A deep dive into how WoundScribe builds simulated patient cases and a clinical white paper your reps can carry into every account.
Reps need clinical evidence they can hand a wound care director without waiting years for a published trial. The Simulation and White Paper package inside the WoundScribe Product Catalog produces exactly that — a professionally prepared white paper anchored in simulated patient cases that mirror how your product performs across real wound phenotypes.
What the package actually produces
The $15,000 Simulation and White Paper package includes everything in the Product Catalog Launch plus a dedicated clinical writing engagement:
- Simulated patient cohort — cases constructed from anonymized trajectory patterns in the healing dashboard, matched to the wound phenotypes your product treats.
- Trajectory modeling — each simulated case shows expected healing curves with and without your product, grounded in the same analytics WoundScribe uses at the point of care.
- Coding and reimbursement narrative — indications, ICD-10 and CPT pairings, and payer rationale are pulled directly from WISER claims and compliance so the story travels cleanly to billing.
- Approved white paper — a formatted document your marketing and compliance teams can approve once and deploy across the field.
How simulated cases are constructed
Each case is built from the same signals WoundScribe captures during a live encounter — measurements from AI-powered wound imaging, treatment history, and healing trajectory. The simulation layer then models plausible response curves for the wound phenotype your product targets. Nothing is invented: the parameters come from aggregate, de-identified trajectory data surfaced through the healing dashboard.
Where the asset lives after delivery
The white paper is yours. Reps carry it into hospital and clinic accounts. Marketing repurposes sections into detail aids and conference handouts. Meanwhile, the underlying product configuration continues to surface at the point of care through the catalog — so the paper and the platform reinforce each other in the same accounts.